News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
77,076 Results
Type
Article (2046)
Company Profile (2)
Press Release (75028)
Section
Business (23329)
Career Advice (10)
Deals (4847)
Drug Development (9638)
FDA (2173)
Job Trends (1122)
News (41045)
Policy (3897)
Tag
Academia (105)
Alliances (8364)
Alzheimer's disease (152)
Approvals (2179)
Artificial intelligence (20)
Best Places to Work (1028)
Biosimilars (14)
Breast cancer (62)
Cancer (368)
Cardiovascular disease (21)
Cell therapy (34)
Clinical research (8537)
Collaboration (100)
Compensation (33)
COVID-19 (222)
Data (372)
Diabetes (23)
Diagnostics (755)
Drug discovery (17)
Earnings (9178)
Events (8214)
Executive appointments (62)
FDA (2352)
Funding (100)
Gene therapy (26)
GLP-1 (57)
Government (262)
Healthcare (1260)
Infectious disease (236)
Inflammatory bowel disease (19)
Intellectual property (12)
IPO (1844)
Job creations (244)
Legal (957)
Liver cancer (19)
Lung cancer (51)
Lymphoma (27)
Manufacturing (32)
Medical device (1283)
Medtech (1284)
Mergers & acquisitions (3092)
Metabolic disorders (60)
Neurodegenerative disease (12)
Neuroscience (213)
NextGen Class of 2024 (254)
Non-profit (75)
Northern California (282)
Obesity (23)
Parkinson's disease (25)
Patents (19)
People (5143)
Phase I (2212)
Phase II (3488)
Phase III (3407)
Pipeline (109)
Postmarket research (339)
Preclinical (753)
Prostate cancer (18)
Radiopharmaceuticals (25)
Rare diseases (39)
Real estate (604)
Regulatory (2909)
Research institute (109)
Series A (22)
Series B (14)
Southern California (241)
Startups (426)
United States (2386)
Vaccines (42)
Date
Last 7 days (148)
Last 30 days (632)
Last 365 days (5495)
2024 (5467)
2023 (4545)
2022 (7805)
2021 (7127)
2020 (6534)
2019 (4285)
2018 (3317)
2017 (3897)
2016 (3442)
2015 (4330)
2014 (3235)
2013 (2717)
2012 (2876)
2011 (3019)
2010 (2781)
Location
Africa (81)
Asia (21434)
Australia (2462)
California (657)
Canada (255)
China (117)
Colorado (29)
Connecticut (44)
Delaware (43)
Europe (14192)
Florida (42)
Georgia (22)
Illinois (43)
Indiana (13)
Japan (53)
Maryland (89)
Massachusetts (546)
Minnesota (40)
Missouri (12)
New Jersey (230)
New York (203)
North Carolina (72)
Northern California (282)
Ohio (14)
Pennsylvania (90)
South America (113)
Southern California (241)
Texas (103)
Virginia (29)
Washington State (45)
Wisconsin (16)
77,076 Results for "f2g ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
F2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at Trends in Medical Mycology (TIMM) 2023 Demonstrating Positive Therapeutic Responses in Patients with Invasive Fungal Infections Treated with Oral Olorofim
F2G Ltd. and Shionogi & Co., Ltd., announced full results from the pivotal Phase 2b open-label study of olorofim in patients with proven invasive fungal infections or probable pulmonary invasive aspergillosis and limited or no treatment options.
October 21, 2023
·
10 min read
F2G to Present at Biotech Showcase™ 2023
F2G Ltd. today announced that the Company’s chief executive officer, Francesco Lavino will provide a corporate overview at Biotech Showcase™ 2023 taking place in San Francisco, California, from January 9-11, 2023.
January 5, 2023
·
4 min read
F2G Receives Complete Response Letter from FDA for New Drug Application for Olorofim for The Treatment of Invasive Fungal Infections; Plans Resubmission With Additional Data and Analyses
F2G Ltd. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for olorofim, an investigational antifungal, for the treatment of invasive fungal infections in patients who have limited or no treatment options.
June 19, 2023
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
December 12, 2024
·
4 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
F2G to Present Interim Results from Phase 2B Open Label Study of Olorofim in Invasive Fungal Infections at IDWeek 2022
F2G Ltd today announced that it will present new clinical data in three oral presentations and two poster presentations at IDWeek 2022, to be held in Washington, D.C. from October 19-23, 2022.
October 13, 2022
·
4 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
1 of 7,708
Next
